The clinical significance of Raynaud's phenomenon in systemic lupus erythematosus.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Journal titleArthritis and rheumatism
Publication Begin page815
Publication End page9
MetadataShow full item record
AbstractIn a prospective study of 226 patients with systemic lupus erythematosus (SLE), 91 patients (40%) had Raynaud's phenomenon. These patients were compared to 135 patients without Raynaud's phenomenon. Patients with Raynaud's phenomenon had a greater incidence of arthritis (P less than 0.02), malar rash (P less than 0.003), and photosensitivity (P less than 0.03), and a lesser incidence of severe renal disease as manifested by serum creatinine over 3.0 mg/dl (P less than 0.007) or creatinine clearance below 60 ml/minute. Patients with Raynaud's phenomenon were less likely to have severe, life threatening disease and received a lower average monthly (P less than 0.01) and a lower peak daily corticosteroid dose (P less than 0.01). Fourteen patients (16%) with Raynaud's phenomenon died, compared to 41 without (30%) (P less than 0.03). Raynaud's phenomenon in patients with SLE is associated with milder disease and may be regarded as a favorable prognostic sign.
CitationDimant J, Ginzler E, Schlesinger M, Sterba G, Diamond H, Kaplan D, Weiner M. The clinical significance of Raynaud's phenomenon in systemic lupus erythematosus. Arthritis Rheum. 1979 Aug;22(8):815-9. doi: 10.1002/art.1780220802. PMID: 465096.
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International
- Raynaud's phenomenon in systemic lupus erythematosus.
- Authors: Lavras Costallat LT, Valente Coimbra AM
- Issue date: 1995 May
- A randomised double-blind trial of diltiazem in the treatment of Raynaud's phenomenon.
- Authors: Kahan A, Amor B, Menkes CJ
- Issue date: 1985 Jan
- [Diagnostic value of thermography in Raynaud's phenomenon associated with systemic lupus erythematosus].
- Authors: Mikulska D
- Issue date: 2009
- Raynaud's phenomenon and antiphospholipid antibodies in systemic lupus erythematosus: is there an association?
- Authors: Caccavo D, Del Porto F, Garzia P, Mitterhofer AP, Galluzzo S, Rigon A, Vadacca M, Navajas MF, Amoroso A, Afeltra A
- Issue date: 2003 Oct
- Clinical Study on Systemic Lupus Erythematosus Complicated with Knee Bone Infarction.
- Authors: Zhu GQ, Qiu HX, Ma XM, Liu MX
- Issue date: 2022